Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) SelectQuote, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3339273 (State or other j ...

SelectQuote, Inc. (NYSE:SLQT) Q1 2023 Results Conference Call November 3, 2022 8:00 AM ET Company Participants Matt Gunter - IR Tim Danker - CEO Ryan Clement - Interim CFO Bob Grant - President Bill Grant - COO Conference Call Participants Daniel Grosslight - Citigroup Jonathan Yong - Credit Suisse Meyer Shields - KBW Operator Welcome to SelectQuote’s First Quarter Earnings Conference Call. [Operator Instructions] It is now my pleasure to introduce Matt Gunter, SelectQuote Investor Relations. Mr. Gunter, yo ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 Securities registered pursuant to Section 12(b) of the Act: | Title of each class | Trading Symbol(s) | Name of each exchange on which ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to SelectQuote, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 94-3339273 (I.R.S. ...

4 th Quarter Fiscal 2022 Earnings Conference Call Presentation August 29, 2022 | We shop. You save. Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," "e ...

Financial Data and Key Metrics Changes - For Q4 2022, consolidated revenue was $139 million, with senior revenue at $98 million, and a net loss of $105 million or negative $0.64 per share [9][42] - The company experienced a 31% increase in agent close rates and a 35% decrease in marketing cost per approved policy compared to the previous year [10][28] - Adjusted EBITDA for Q4 was negative $61 million, or negative $13 million excluding a $48 million cohort tail adjustment [42] Business Line Data and Key Metrics Changes - Total improved policies from the senior division increased to 144,000, up 23% year-over-year [44] - The Life business saw a reduction in revenue due to lower term life premiums, attributed to fewer agents and COVID-related conversion issues [42] - Auto & Home revenue remained flat year-over-year [42] Market Data and Key Metrics Changes - The company anticipates a 35% to 45% decline in Medicare Advantage policy production for 2023, aligning with its strategy to focus on consistent returns rather than pure growth [15][56] - The healthcare services business, primarily SelectRx, is projected to generate over $275 million in revenue for fiscal year 2023 [24][59] Company Strategy and Development Direction - The company is shifting its focus from growth to generating consistent unit economics and cash flow, with a goal of achieving cash EBITDA breakeven in fiscal 2023 [12][16] - Cost reductions exceeding $250 million have been identified, including around $40 million in fixed expenses [19][60] - The strategy includes a more tenured agent sales force and targeted marketing to improve productivity and customer retention [18][31] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about early achievements since the strategic redesign, noting improvements in customer retention trends [7][11] - The company is confident that the adjustments made have significantly de-risked potential future adjustments in financial results [13][23] - Management emphasized the importance of establishing credibility with investors through improved financial results [40][110] Other Important Information - The company has completed hiring its sales agent force for the upcoming AEP season and is focused on training and onboarding [20][29] - A credit covenant amendment has been agreed upon with lenders, providing adequate liquidity for operations in the coming quarters [62][106] Q&A Session Summary Question: What is different about the agent hiring for the 2023 AEP season? - Management highlighted that they secured flex agents early and improved training processes, leading to better quality and readiness compared to previous years [65][66] Question: What gives comfort that the $875 LTV is appropriate for fiscal 2023? - Management noted that the majority of switching occurs in the first year, providing better visibility into cash streams from older cohorts, and emphasized the conservative nature of their assumptions [68][70] Question: Can you provide color on MA enrollment and policy growth rates? - Management confirmed a pullback in overall policy production as part of the strategic redesign, but expressed confidence in the market opportunity for future growth [73][76] Question: Can you elaborate on the credit covenant changes? - Management confirmed that the amendments include a step increase in the overall interest rate but provide necessary liquidity for operations [84][106] Question: How will the slowdown in MA membership acquisition impact SelectRx growth? - Management expressed confidence in the synergistic relationship between MA policies and SelectRx, indicating room for growth despite potential slowdowns in MA membership [90][91]

| --- | --- | --- | --- | --- | |-------|---------------------------------------------------|-------|-------|-------| | | Quarter Fiscal 2022 | | | | | | Earnings Conference Call Presentation May 5, 2022 | | | | | We shop. You save. Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, m ...

SelectQuote, Inc. (NYSE:SLQT) Q3 2022 Earnings Conference Call May 5, 2022 8:30 AM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Raff Sadun - Chief Financial Officer Bill Grant - Chief Operating Officer Conference Call Participants Daniel Grosslight - Citi Jeff Garro - Piper Sandler Jonathan Yong - Credit Suisse Thomas McJoynt-Griffith - KBW Operator Welcome to the SelectQuote's Third Quarter Earnings Conference Call. All lines have been placed on mute to pr ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 (913) 599-9225 (Registrant's telephone number, including area code) (Former name, former address and former fiscal year, if changed since last report) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) SelectQuote, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3339273 (State or other j ...